outcomes of limited stage peripheral t-cell lymphoma
Published 4 years ago • 721 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
8:57
outcomes of sct in t-all and t-lbl
-
3:31
advancements in peripheral t cell lymphoma
-
2:41
improved outcomes in ptcl with the use of novel agents and transplantation
-
2:19
session highlights: autosct in t-cell lymphoma, classification updates and fertility preservation
-
3:36
the long-term outcomes of consolidative allosct for bpdcn
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
48:20
airrc7 - leveraging single-cell tcr-sequencing to investigate mucosal t cell biology (n. provine)
-
58:27
laboratory nonconformance (event) management
-
5:45
t-cell receptor repertoire sequencing - a missing piece of the immuno-oncology puzzle?
-
1:31
pegenzileukin for t-cell dysfunction
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:11
the t-cell lymphoma project: prospective data collection changing the world
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
1:09
sequencing of therapies to improve outcomes of cll patients
-
2:30
towards strategies to optimize outcomes in cll
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
3:01
t-cell engaging antibodies: novel combinations to overcome resistance
-
1:03
measuring cell avidity to assess the efficacy of t-cell therapies